Dr. Hincapie-Castillo has been appointed to the Science and Policy Advisory Council for the National Pain Advocacy Center.
The PhRMA Foundation solicited proposals on how value assessment can better capture evidence regarding diverse populations and drivers of health disparities.
Early bird registration rates are available until April 1, for the Cannabis Clinical Outcomes Research Conference.
Pain Medicine is a multidisciplinary journal dedicated to pain clinicians, educators and researchers with an interest in pain from various medical specialties.
Hincapie-Castillo will collaborate with faculty and staff in The Center for Public Health Law Research on projects and grants in the area of legal epidemiology.
Read about the student achievements making news in the department of pharmaceutical outcomes and policy's student newsletter.
The peer-reviewed journal is one of the oldest and most impactful journals dedicated exclusively to gerontology and geriatrics.
The Quality Metrics Expert Panel is a small group of experts who meet monthly to recommend measures for testing and for endorsement by the Pharmacy Quality Alliance.
The Department of pharmaceutical outcomes and policy welcomes Jingchuan “Serena” Guo, Ph.D., M.D., M.P.H., as a new assistant professor. Guo’s research is built at the intersection of epidemiology, and pharmaceutical health services and outcome research, with a focus on diabetes and cardiorenal outcomes. She uses large healthcare databases and…
The Brandeis/Harvard National Institute on Drug Abuse workshop is titled "Applying group-based trajectory modeling in health outcomes research."